All Updates

All Updates

icon
Filter
Partnerships
Better Therapeutics partners with Glooko to accelerate adoption of AspyreRx for type 2 diabetes management
Preventive Healthcare
Jan 3, 2024
This week:
Partnerships
Microsoft and BlackRock partner to launch USD 30 billion AI data center investment fund
Machine Learning Infrastructure
Yesterday
Funding
Limitless Labs raises USD 3 million in pre-seed funding to develop prediction market
Web3 Ecosystem
Yesterday
Product updates
Google Cloud launches Blockchain RPC service for Web3 developers
Web3 Ecosystem
Yesterday
Product updates
Kore.ai launches GALE platform for enterprise GenAI adoption
Machine Learning Infrastructure
Yesterday
Product updates
Kore.ai launches GALE platform for enterprise GenAI adoption
Generative AI Infrastructure
Yesterday
Partnerships
Climeworks partners with Terraset to enable philanthropic support for carbon removal
Carbon Capture, Utilization & Storage (CCUS)
Sep 17, 2024
Funding
8 Rivers secures investment from JX Nippon to commercialize DAC technology
Carbon Capture, Utilization & Storage (CCUS)
Sep 17, 2024
Product updates
ProAmpac launches enhanced online pouch configurator MAKR by DASL for custom flexible packaging prototypes
Smart Packaging Tech
Sep 17, 2024
Funding
M&A
Majority stake in Bollegraaf Group acquired by Summa Equity for EUR 800 million
Waste Recovery & Management Tech
Sep 17, 2024
Partnerships
NASA awards Intuitive Machines contract for near-space network services
Space Travel and Exploration Tech
Sep 17, 2024
Preventive Healthcare

Preventive Healthcare

Jan 3, 2024

Better Therapeutics partners with Glooko to accelerate adoption of AspyreRx for type 2 diabetes management

Partnerships

  • Better Therapeutics, a prescription digital therapeutic startup, has collaborated with Glooko, a remote patient monitoring and diabetes care platform. The partnership will focus on integrating Better Therapeutics' recently launched AspyreRx , a digital behavioral treatment for type 2 diabetes (T2D), into Glooko's platform.

  • The collaboration will identify potential patients for AspyreRx treatment and enable healthcare professionals to prescribe and monitor digital therapeutics.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.